SYNGAP1 is increasingly recognized as a candidate gene in neurodevelopmental disorders, with haploinsufficiency leading to intellectual disability (SYNGAP1-ID), epilepsy, autism spectrum disorder, sensory processing deficits, including in the auditory domain, and other behavioral abnormalities (Hamdan et al., 2009; Berryer et al., 2013; Carreño-Muñoz et al., 2022). This evidence concerns the gene SYNGAP1 and autism spectrum disorder.